February 21, 2023, 8:00 a.m. MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity BBSRB 331

Add to Calendar

Add to Google Calendar

Add to iCal

Add to Outlook

Event Details

MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity

CVRC Cardiovascular Journal Club

BBSRB 331

Gregory Graf

Event Attachments

MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity.pdf

Upcoming Events

Multiscale Modeling of the Heart: Insights into Health and Disease

GO TO EVENT

GO TO EVENT

Dr. Koenig's primary focus is on understanding the role of inflammatory and non…

GO TO EVENT